Webinar Week: 2021 Global Biopharmaceutical Industry Trends

A Look Ahead with Frost & Sullivan

Tuesday, February 23, 2021 | 10am ET / 4pm CET

Next Generation Biopharmaceutical Manufacturing Platforms


  • Nitin Naik, Global Practice Area Leader, Healthcare & Life Sciences, Frost & Sullivan
  • Alexei Voloshin, Global Manager Biopharma Application Development, 3M
  • Hani El-Sabbahy, Biopharmaceutical Purification Application Engineering Specialist, 3M
  • Joris Van de Velde, Senior Application Engineer Biopharmaceutical Purification, 3M
  • Andrew Sinclair, President and Founder, BioPharm
Advancing Bioprocessing through Materials Science

Innovation in bioprocess strategies are enabled by new technologies. 3M™ advanced materials platforms and bioprocess expertise are used to enable process intensification and single use transition through creation of high-performance smart unit operations. In this session we look at how the interface between materials technology and bioprocessing is used to define and to accelerate key trends in the industry.

Key Take-Aways:

  • Materials science drives innovation in bioprocessing
  • Process compression is enabled by smarter unit operations
  • Next generation of bioprocessing requires a step change in technology
Modelling the Processes of Future
Elucidating the value of process intensification using computational modeling.

Key Take-Aways:

  • High product recovery across unit operations facilitate process intensification
  • Performance of unit operations directly affects efficiency of the process
  • Single use process transition increases flexibility and productivity

Panel Discussion: Designing Efficient and Economical Processes for Futures